These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 571341

  • 1. Dopaminergic effects of non-hydroxylated rigid analogs of apomorphine.
    Rusterholz DB, Long JP, Flynn JR, Cannon JG, Lee T, Pease JP, Clemens JA, Wong DT, Bymaster FP.
    Eur J Pharmacol; 1979 Apr 01; 55(1):73-82. PubMed ID: 571341
    [Abstract] [Full Text] [Related]

  • 2. Apomorphine-induced rotation in normal rats and interaction with unilateral caudate lesions.
    Jerussi TP, Glick SD.
    Psychopharmacologia; 1975 Apr 01; 40(4):329-34. PubMed ID: 1096216
    [Abstract] [Full Text] [Related]

  • 3. Dopaminergic activity of some apomorphine analogs.
    Cheng HC, Long JP, Van Orden LS, Cannon JG, O'Donnell JP.
    Res Commun Chem Pathol Pharmacol; 1976 Sep 01; 15(1):89-106. PubMed ID: 968179
    [Abstract] [Full Text] [Related]

  • 4. Cholinergic effects of molecular segments of apomorphine and dopaminergic effects of N,N-dialkylated dopamines.
    Ginos JZ, Cotzias GC, Tolosa E, Tang LC, LoMonte A.
    J Med Chem; 1975 Dec 01; 18(12):1194-1200. PubMed ID: 1238569
    [Abstract] [Full Text] [Related]

  • 5. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
    Costall B, Naylor RJ, Neumeyer JL.
    Eur J Pharmacol; 1975 Mar 01; 31(1):1-16. PubMed ID: 1168579
    [Abstract] [Full Text] [Related]

  • 6. Further dopaminergic supersensitivity to dopamine agonists by subchronic administration of haloperidol in rats treated with colchicine.
    Kamata K, Okuyama S, Hashimoto S, Aihara H, Kasuya Y.
    Jpn J Pharmacol; 1986 Oct 01; 42(2):329-32. PubMed ID: 3795627
    [Abstract] [Full Text] [Related]

  • 7. Haloperidol-induced plasma prolactin release: sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the rat.
    Feigenbaum JJ, Moon BH, Catterton R, Yanai J, Klawans HL.
    Psychopharmacology (Berl); 1982 Oct 01; 78(4):383-4. PubMed ID: 6818604
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of structural and stereoisomers of apomorphine on stereotyped behavior of the rat.
    Schoenfeld RI, Neumeyer JL, Dafeldecker W, Roffler-Tarlov S.
    Eur J Pharmacol; 1975 Jan 01; 30(1):63-8. PubMed ID: 1168137
    [Abstract] [Full Text] [Related]

  • 9. Design of agents for stimulation of neostriatal dopaminergic mechanisms.
    Costall B, Naylor RJ, Pinder RM.
    J Pharm Pharmacol; 1974 Oct 01; 26(10):753-6. PubMed ID: 4156532
    [No Abstract] [Full Text] [Related]

  • 10. The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent.
    Koller WC, Weiner WJ, Diamond BI, Nausieda PA, Klawans HL.
    Neuropharmacology; 1980 Sep 01; 19(9):831-7. PubMed ID: 7191490
    [No Abstract] [Full Text] [Related]

  • 11. Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and alpha-methyl-p-tyrosine.
    Friedman E, Rotrosen J, Gurland M, Lambert GA, Gershon S.
    Life Sci; 1975 Sep 15; 17(6):867-73. PubMed ID: 1238887
    [No Abstract] [Full Text] [Related]

  • 12. Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.
    Horowski R, Wachtel H.
    Eur J Pharmacol; 1976 Apr 15; 36(2):373-83. PubMed ID: 945166
    [Abstract] [Full Text] [Related]

  • 13. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB, Wyder KJ, Jakubovic A, Fibiger HC.
    Br J Pharmacol; 1990 Mar 15; 99(3):509-15. PubMed ID: 2110017
    [Abstract] [Full Text] [Related]

  • 14. Is morphine-induced catalepsy related to activation of dopaminergic neurones?
    Moleman P, Versluis DJ, Bruinvels J.
    Psychopharmacology (Berl); 1978 Dec 15; 60(1):35-9. PubMed ID: 104343
    [No Abstract] [Full Text] [Related]

  • 15. Hypothermic effects of apomorphine homologues in mice.
    Menon MK, Clark WG, Cannon JG.
    J Pharm Pharmacol; 1979 May 15; 31(5):318-21. PubMed ID: 37302
    [Abstract] [Full Text] [Related]

  • 16. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B, Naylor RJ, Pycock C.
    Eur J Pharmacol; 1976 Feb 15; 35(2):276-83. PubMed ID: 942921
    [Abstract] [Full Text] [Related]

  • 17. The function of dopamine and its antagonism in the caudate nucleus of cats in relation to the stereotyped behaviour.
    Cools AR.
    Arch Int Pharmacodyn Ther; 1971 Dec 15; 194(2):259-69. PubMed ID: 5126063
    [No Abstract] [Full Text] [Related]

  • 18. Effects of penfluridol and other drugs on apomorphine-induced stereotyped behavior in monkeys.
    Shintomi K, Yamamura M.
    Eur J Pharmacol; 1975 Apr 15; 31(2):273-80. PubMed ID: 1171014
    [Abstract] [Full Text] [Related]

  • 19. Dopaminergic effects of lergotrile: possible involvement of a metabolite.
    McDevitt JT, Setler PE.
    Neuropharmacology; 1980 Jun 15; 19(6):537-42. PubMed ID: 6105627
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine.
    Menon MK, Clark WG, Neumeyer JL.
    Eur J Pharmacol; 1978 Nov 01; 52(1):1-9. PubMed ID: 569056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.